Inari Medical, Inc.

NASDAQ (USD): Inari Medical, Inc. (NARI)

Last Price

43.69

Today's Change

-0.69 (1.55%)

Day's Change

43.25 - 45.18

Trading Volume

1,155,823

Profile
NARI

Exchange:  NASDAQ Global Select NASDAQ Global Select

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Andrew J. Hykes Mr. Andrew J. Hykes

Full Time Employees:  1,300 1,300

IPO Date:  2020-05-22 2020-05-22

CIK:  0001531048 0001531048

ISIN:  US45332Y1091 US45332Y1091

CUSIP:  45332Y109 45332Y109

Beta:  1.00 1.00

Last Dividend:  0.00 0.00

Dcf Diff:  84.64 84.64

Dcf:  -40.86 -40.86

Description

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Address

6001 Oak Canyon,
Irvine, CA 92618, US

877 923 4747

http://www.inarimedical.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment